Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serotonin secretion by enterochromaffin cells is a key process in gut physiology. EC cells, the most numerous enteroendocrine cells in the GI tract, synthesize serotonin from tryptophan via tryptophan hydroxylase 1 (TPH1), store it in vesicles via VMAT1, and release it in response to luminal stimuli such as nutrients, microbial metabolites (e.g., indoles), and mechanical forces. Released serotonin acts locally, activating sensory and motor neurons (primarily via 5-HT3 and 5-HT4 receptors), modulating motility, secretion, and communicating satiety signals to the brain. Dysregulation of EC cell serotonin secretion is implicated in numerous GI and metabolic diseases, as well as chemotherapy-induced nausea and vomiting; thus, several molecular actors involved in this process form therapeutic targets.
Antagonism/inhibition of 5-HT3 receptors (reduces nausea/vomiting) Modulation of serotonin synthesis/release (e.g., by targeting TPH1 or TRPA1) Alteration of serotonin reuptake or degradation Modulation of enterochromaffin cell activity via microbial metabolites or nutrients
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin secretion mechanism in enterochromaffin cell of gastrointestinal tract.